| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |